Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BNTC
#2504
Benitec Biopharma Inc. Common Stock
10.900
0
-0.05%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-0.05%
Aylık değişim
-12.03%
6 aylık değişim
-34.38%
Yıllık değişim
-34.38%
Önceki kapanış
10.905
0
Open
10.900
0
Bid
Ask
Low
10.900
0
High
10.900
0
Hacim
21
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
BNTC
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
TTM
Key stats
Total common shares outstanding
25.6 M
26.25 M
33.86 M
34.35 M
—
Valuation ratios
Enterprise value
229.46 M
209.43 M
380.59 M
273.95 M
1.09 B
Price to earnings ratio
-20.33
-11.14
-12.09
-12.36
-55.92
Price to sales ratio
—
507.36
-1 553.57
-1 491.56
—
Price to cash flow ratio
-7.79
-17.96
-19.05
-28.68
-73.48
Price to book ratio
0.55
4.35
1.29
1.17
7.36
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.09
0.09
0.06
0.33
Return on equity %
0.1
0.09
0.1
0.06
0.35
Return on invested capital %
—
—
—
—
—
Gross margin %
—
100
—
—
—
Operating margin %
—
-4 581.35
—
—
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
-2 692.66
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
14.8
54.67
46.95
67.69
184.12
Inventory turnover
—
—
—
—
—
Asset turnover
0
-0
0
0
-0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.08
0.23
0.08
0.08
0.47
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
2.68
2.7
2.28
4.11
11.77
Net current asset value per share
2.69
2.72
2.29
4.12
11.83
Tangible book value per share
2.53
2.69
2.25
4.08
11.54
Working capital per share
2.51
2.67
2.24
4.06
11.49
Book value per share
2.53
2.69
2.25
4.08
11.54
Haberler
基因疗法数据公布后Benitec BioPharma股票评级维持不变
Benitec BioPharma stock rating maintained on gene therapy data
Benitec to present BB-301 gene therapy study results in March
Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade
Citizens维持Benitec BioPharma股票的"市场跑赢"评级
Citizens reiterates Market Outperform rating on Benitec BioPharma stock
TD Cowen维持Benitec BioPharma买入评级,OPMD数据强劲
Benitec BioPharma stock maintains Buy rating at TD Cowen on strong OPMD data
贝尔德重申Benitec BioPharma股票"跑赢大盘"评级,目标价30美元
Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target
Benitec的基因疗法在OPMD患者中显示持久疗效
Benitec’s gene therapy shows durable results in OPMD patients